Immunization strategies against henipaviruses

Current Topics in Microbiology and Immunology

Volumn 359, Issue , 2012, Pages 197-223

  Broder, Christopher C ^a   Geisbert, Thomas W ^b   Xu, Kai ^c   Nikolov, Dimitar B ^c   Wang, Lin Fa ^d   Middleton, Deborah ^d   Pallister, Jackie ^d   Bossart, Katharine N ^e  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d CSIRO   (Australia)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY M102.4; POLYCLONAL ANTIBODY; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

ACTIVE IMMUNIZATION; ANTIBODY SPECIFICITY; ARTICLE; DISEASE MODEL; DRUG EFFICACY; EXPERIMENTAL ANIMAL; EXPERIMENTAL INFECTION; FATALITY; HENDRA VIRUS; HENIPAVIRUS INFECTION; HUMAN; IMMUNIZATION; NIPAH VIRUS; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; VIRAL TROPISM; VIRUS PATHOGENESIS; VIRUS RECOMBINANT;

ANIMALS; ANTIBODIES; HENDRA VIRUS; HENIPAVIRUS INFECTIONS; HUMANS; IMMUNIZATION, PASSIVE; NIPAH VIRUS; VACCINATION; VACCINES, SUBUNIT; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRAL TROPISM; VIRAL VACCINES;

ANIMALIA; HENDRA VIRUS; HENIPAVIRUS; MAMMALIA; NIPAH VIRUS; PARAMYXOVIRIDAE;

EID: 84864879265     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82-2012-213     Document Type: Article

References (106)

1. Aebersold P (2012) FDA experience with medical countermeasures under the animal rule. Adv Prev Med 2012:507-571
2. Anonymous (2008) Hendra virus, human, equine - Australia (04), Queensland. Pro-MED-mail, International Society for Infectious Diseases, 25 July, archive no. 20080725.2260. Available at www.promedmail.org
3. Anonymous (2009) Human, Equine - Australia (04), Queensland Fatal. Pro-MED-mail, International Society for Infectious Diseases, 3 Sep, archive no. 20090903.3098. Available at www.promedmail.org
4. Anonymous (2011) Hendra Virus, Equine - Australia (28), Queensland, New South Wales. Pro-MED-mail International Society for Infectious Diseases, 12 Oct, archive no. 20111013.3061. Available at www.promedmail.org
5. Anonymous (2012a) Hendra virus, equine - Australia, Queensland. Pro-MED-mail International Society for Infectious Diseases, 6 Jan, archive no. 20120106.1001359. Available at www.promedmail.org
6. Anonymous (2012b) Nipah encephalitis, human - Bangladesh, Jipurhat. Pro-MED-mail, International Society for Infectious Diseases, 7 Feb, archive no. 20120212.1040138. Available at www.promedmail.org
7. Balzer M (2011) Hendra vaccine success announced. Aust Vet J 89(7):N2-N3
8. Bishop KA, Broder CC (2008) Hendra and Nipah: lethal zoonotic paramyxoviruses. In: Scheld WM, Hammer SM, Hughes JM (eds) Emerging infections. American Society for Microbiology, Washington, pp 155-187
9. Bishop KA, Stantchev TS, Hickey AC, Khetawat D, Bossart KN, Krasnoperov V, Gill P, Feng YR, Wang L, Eaton BT, Wang LF, Broder CC (2007) Identification of hendra virus G glycoprotein residues that are critical for receptor binding. J Virol 81(11):5893-5901 (Pubitemid 46850649)
10. Bonaparte MI, Dimitrov AS, Bossart KN, Crameri G, Mungall BA, Bishop KA, Choudhry V, Dimitrov DS, Wang LF, Eaton BT, Broder CC (2005) Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc Natl Acad Sci U S A 102(30):10652-10657 (Pubitemid 41061609)
11. Bossart KN, Crameri G, Dimitrov AS, Mungall BA, Feng YR, Patch JR, Choudhary A, Wang LF, Eaton BT, Broder CC (2005) Receptor binding, fusion inhibition and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of hendra virus. J Virol 79(11):6690-6702 (Pubitemid 40677300)
12. Bossart KN, McEachern JA, Hickey AC, Choudhry V, Dimitrov DS, Eaton BT, Wang LF (2007) Neutralization assays for differential henipavirus serology using bio-plex protein array systems. J Virol Methods 142(1-2):29-40 (Pubitemid 46613909)
13. Bossart KN, Tachedjian M, McEachern JA, Crameri G, Zhu Z, Dimitrov DS, Broder CC, Wang LF (2008) Functional studies of host-specific ephrin-B ligands as henipavirus receptors. Virology 372(2):357-371 (Pubitemid 351284563)
14. Bossart KN, Zhu Z, Middleton D, Klippel J, Crameri G, Bingham J, McEachern JA, Green D, Hancock TJ, Chan YP, Hickey AC, Dimitrov DS, Wang LF, Broder CC (2009) A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute Nipah virus infection. PLoS Pathog 5(10):e1000642
15. Bossart KN, Geisbert TW, Feldmann H, Zhu Z, Feldmann F, Geisbert JB, Yan L, Feng YR, Brining D, Scott D, Wang Y, Dimitrov AS, Callison J, Chan YP, Hickey AC, Dimitrov DS, Broder CC, and Rockx B (2011) A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge. Sci Transl Med 3(105):103-105
16. Bowden TA, Aricescu AR, Gilbert RJ, Grimes JM, Jones EY, Stuart DI (2008) Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2. Nat Struct Mol Biol 15(6):567-572 (Pubitemid 351799140)
17. Bowden TA, Crispin M, Harvey DJ, Jones EY, Stuart DI (2010) Dimeric architecture of the hendra virus attachment glycoprotein: evidence for a conserved mode of assembly. J Virol 84(12):6208-6217
18. Broder CC, Earl PL, Long D, Abedon ST, Moss B, Doms RW (1994) Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and sensitive monoclonal antibodies. Proc Natl Acad Sci U S A 91(24):11699-11703 (Pubitemid 24356412)
19. Casadevall A, Dadachova E, Pirofski LA (2004) Passive antibody therapy for infectious diseases. Nat Rev Microbiol 2(9):695-703 (Pubitemid 39200062)
20. Chong HT, Tan CT (2003) Relapsed and late-onset Nipah encephalitis, a report of three cases. Neurol J Southeast Asia 8:109-112
21. Chua KB, Goh KJ, Wong KT, Kamarulzaman A, Tan PS, Ksiazek TG, Zaki SR, Paul G, Lam SK, Tan CT (1999) Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet 354(9186):1257-1259 (Pubitemid 29469355)
22. Chua KB, Lek Koh C, Hooi PS, Wee KF, Khong JH, Chua BH, Chan YP, Lim ME, Lam SK (2002) Isolation of Nipah virus from Malaysian island flying-foxes. Microbes Infect 4(2):145-151 (Pubitemid 34183487)
23. Colgrave ML, Snelling HJ, Shiell BR, Feng YR, Chan YP, Bossart KN, Xu K, Nikolov DB, Broder CC, Michalski WP (2012) Site occupancy and glycan compositional analysis of two soluble recombinant forms of the attachment glycoprotein of hendra virus. Glycobiology 22(4):572-584
24. Crawford LM (2002) New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Office of the Federal Register, National Archives and Records Administration (NARA), Washington, pp 37988-37998
25. Drexler JF, Corman VM, Gloza-Rausch F, Seebens A, Annan A, Ipsen A, Kruppa T, Muller MA, Kalko EK, Adu-Sarkodie Y, Oppong S, Drosten C (2009) Henipavirus RNA in African bats. PLoS One 4(7):e6367
26. Dutch RE (2010) Entry and fusion of emerging paramyxoviruses. PLoS Pathog 6(6):e1000881
27. Eaton BT, Broder CC, Middleton D, Wang LF (2006) Hendra and Nipah viruses: different and dangerous. Nat Rev Microbiol 4(1):23-35 (Pubitemid 43135284)
28. Eaton BT, Mackenzie JS, Wang L-F (2007) Henipaviruses. In: Knipe DM, Howley PM (eds) Fields virology. Lippincott Williams & Wilkins, Philadelphia, pp 1587-1600
29. Field HE, Mackenzie JS, Daszak P (2007) Henipaviruses: emerging paramyxoviruses associated with fruit bats. Curr Top Microbiol Immunol 315:133-159
30. Field H, Schaaf K, Kung N, Simon C, Waltisbuhl D, Hobert H, Moore F, Middleton D, Crook A, Smith G, Daniels P, Glanville R, Lovell D (2010) Hendra virus outbreak with novel clinical features Australia. Emerg Infect Dis 16(2):338-340
31. Gale NW, Baluk P, Pan L, Kwan M, Holash J, DeChiara TM, McDonald DM, Yancopoulos GD (2001) Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev Biol 230(2):151-160 (Pubitemid 32171414)
32. Geisbert TW, Daddario-DiCaprio KM, Hickey AC, Smith MA, Chan YP, Wang LF, Mattapallil JJ, Geisbert JB, Bossart KN, Broder CC (2010) Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection. PLoS One 5(5):e10690
33. Griffin DE (1995) Immune responses during measles virus infection. Curr Top Microbiol Immunol 191:117-134
34. Guillaume V, Contamin H, Loth P, Georges-Courbot MC, Lefeuvre A, Marianneau P, Chua KB, Lam SK, Buckland R, Deubel V, Wild TF (2004) Nipah virus: vaccination and passive protection studies in a hamster model. J Virol 78(2):834-840 (Pubitemid 38067605)
35. Guillaume V, Contamin H, Loth P, Grosjean I, Courbot MC, Deubel V, Buckland R, Wild TF (2006) Antibody prophylaxis and therapy against Nipah virus infection in hamsters. J Virol 80(4):1972-1978 (Pubitemid 43228737)
36. Guillaume V, Wong KT, Looi RY, Georges-Courbot MC, Barrot L, Buckland R, Wild TF, Horvat B (2009) Acute hendra virus infection: analysis of the pathogenesis and passive antibody protection in the hamster model. Virology 387(2):459-465
37. Gurley ES, Montgomery JM, Hossain MJ, Bell M, Azad AK, Islam MR, Molla MA, Carroll DS, Ksiazek TG, Rota PA, Lowe L, Comer JA, Rollin P, Czub M, Grolla A, Feldmann H, Luby SP, Woodward JL, Breiman RF (2007) Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis 13(7):1031-1037 (Pubitemid 47048075)
38. Halpin K, Young PL, Field HE, Mackenzie JS (2000) Isolation of hendra virus from pteropid bats: a natural reservoir of hendra virus. J Gen Virol 81(Pt 8):1927-1932 (Pubitemid 30599172)
39. Harcourt BH, Lowe L, Tamin A, Liu X, Bankamp B, Bowden N, Rollin PE, Comer JA, Ksiazek TG, Hossain MJ, Gurley ES, Breiman RF, Bellini WJ, Rota PA (2005) Genetic characterization of Nipah virus, Bangladesh 2004. Emerg Infect Dis 11(10):1594-1597 (Pubitemid 41384348)
40. Hayman DT, Suu-Ire R, Breed AC, McEachern JA, Wang L, Wood JL, Cunningham AA (2008) Evidence of henipavirus infection in west african fruit bats. PLoS ONE 3(7):e2739
41. Hayman DT, Wang LF, Barr J, Baker KS, Suu-Ire R, Broder CC, Cunningham AA, Wood JL (2011) Antibodies to henipavirus or henipa-like viruses in domestic pigs in Ghana, West Africa. PLoS One 6(9):e25256
42. Hickey AC, Bossart KN, Rockx B, Feldmann F, Geisbert JB, Yan L, Feng YR, Feldmann H, Geisbert TW, Broder CC (2011) Vaccination of nonhuman primates with a recombinant soluble henipavirus attachment G glycoprotein protects against lethal Nipah virus challenge. Am Soc Virol 40-2:195
43. Homaira N, Rahman M, Hossain MJ, Epstein JH, Sultana R, Khan MS, Podder G, Nahar K, Ahmed B, Gurley ES, Daszak P, Lipkin WI, Rollin PE, Comer JA, Ksiazek TG, Luby SP (2010) Nipah virus outbreak with person-to-person transmission in a district of Bangladesh 2007. Epidemiol Infect 138(11):1630-1636
44. Hooper PT, Ketterer PJ, Hyatt AD, Russell GM (1997a) Lesions of experimental equine morbillivirus pneumonia in horses. Vet Pathol 34(4):312-322 (Pubitemid 127471113)
45. Hooper PT, Westbury HA, Russell GM (1997b) The lesions of experimental equine morbillivirus disease in cats and guinea pigs. Vet Pathol 34(4):323-329 (Pubitemid 127471114)
46. Hooper P, Zaki S, Daniels P, Middleton D (2001) Comparative pathology of the diseases caused by hendra and Nipah viruses. Microbes Infect 3(4):315-322 (Pubitemid 32385781)
47. Iehle C, Razafitrimo G, Razainirina J, Andriaholinirina N, Goodman SM, Faure C, Georges-Courbot MC, Rousset D, Reynes JM (2007) Henipavirus and tioman virus antibodies in pteropodid bats. Madagascar. Emerg Infect Dis 13(1):159-161 (Pubitemid 46057858)
48. Kang AS, Jones TM, Burton DR (1991) Antibody redesign by chain shuffling from random combinatorial immunoglobulin libraries. Proc Natl Acad Sci U S A 88(24):11120-11123 (Pubitemid 21915991)
49. Kelley LA, Sternberg MJ (2009) Protein structure prediction on the web: a case study using the phyre server. Nat Protoc 4(3):363-371
50. Lackmann M, Boyd AW (2008) Eph, a protein family coming of age: more confusion, insight, or complexity? Sci Signal 1(15): re2
51. Lamb RA, Parks GD (2007) Paramyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology. Lippincott Williams & Wilkins, Philadelphia, pp 1449-1496
52. Lamb RA, Collins PL, Kolakofsky D, Melero JA, Nagai Y, Oldstone MBA, Pringle CR, Rima BK (2005) Family Paramyxoviridae. In: Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA (eds) Virus taxonomy: the classification and nomenclature of viruses. The eighth report of the international committee in taxonomy of viruses. Elsevier Academic Press, San Diego, pp 655-668
53. Lee B, Ataman ZA (2011) Modes of paramyxovirus fusion: a henipavirus perspective. Trends Microbiol 19(8):389-399
54. Li Y, Wang J, Hickey AC, Zhang Y, Wu Y, Zhang H, Yuan J, Han Z, McEachern J, Broder CC, Wang LF, Shi Z (2008) Antibodies to Nipah or Nipah-like viruses in bats. China. Emerg Infect Dis 14(12):1974-1976
55. Li M, Embury-Hyatt C, Weingartl HM (2010) Experimental inoculation study indicates swine as a potential host for hendra virus. Vet Res 41(3):33
56. Luby SP, Hossain MJ, Gurley ES, Ahmed BN, Banu S, Khan SU, Homaira N, Rota PA, Rollin PE, Comer JA, Kenah E, Ksiazek TG, Rahman M (2009) Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001-2007. Emerg Infect Dis 15(8):1229-1235
57. Marianneau P, Guillaume V, Wong T, Badmanathan M, Looi RY, Murri S, Loth P, Tordo N, Wild F, Horvat B, Contamin H (2010) Experimental infection of squirrel monkeys with Nipah virus. Emerg Infect Dis 16(3):507-510
58. Marsh GA, Haining J, Hancock TJ, Robinson R, Foord A, Barr JA, Riddell S, Heine H, White JR, Crameri G, Field HE, Middleton D, Wang LF (2011) Experimental infection of horses with hendra virus/Australia/Horse/2008/ Redlands; implications for control of transmission to people and horses. Emerg Infect Dis 17(12):2232-2238
59. McEachern JA, Bingham J, Crameri G, Green DJ, Hancock TJ, Middleton D, Feng YR, Broder CC, Wang LF, Bossart KN (2008) A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats. Vaccine 26(31):3842-3852
60. Middleton DJ, Westbury HA, Morrissy CJ, van der Heide BM, Russell GM, Braun MA, Hyatt AD (2002) Experimental Nipah virus infection in pigs and cats. J Comp Pathol 126(2-3):124-136
61. Middleton DJ, Morrissy CJ, van der Heide BM, Russell GM, Braun MA, Westbury HA, Halpin K, Daniels PW (2007) Experimental Nipah Virus Infection in Pteropid Bats (Pteropus poliocephalus). J Comp Pathol 136(4):266-272 (Pubitemid 46692426)
62. Mungall BA, Middleton D, Crameri G, Bingham J, Halpin K, Russell G, Green D, McEachern J, Pritchard LI, Eaton BT, Wang LF, Bossart KN, Broder CC (2006) Feline model of acute Nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine. J Virol 80(24):12293-12302 (Pubitemid 44904379)
63. Mungall BA, Middleton D, Crameri G, Halpin K, Bingham J, Eaton BT, Broder CC (2007) Vertical transmission and fetal replication of Nipah virus in an experimentally infected cat. J Infect Dis 196(6):812-816 (Pubitemid 47378929)
64. Murray K, Selleck P, Hooper P, Hyatt A, Gould A, Gleeson L, Westbury H, Hiley L, Selvey L, Rodwell B et al (1995) A morbillivirus that caused fatal disease in horses and humans. Science 268(5207):94-97
65. Murray K, Eaton B, Hooper P, Wang L, Williamson M, Young P (1998) Flying foxes, horses, and humans: a zoonosis caused be a new member of the Paramyxoviridae. In: Scheld WM, Armstrong D, Hughes JM (eds) Emerging infections. ASM Press, Washington, pp 43-58
66. Negrete OA, Levroney EL, Aguilar HC, Bertolotti-Ciarlet A, Nazarian R, Tajyar S, Lee B (2005) EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature 436(7049):401-405 (Pubitemid 41059050)
67. Negrete OA, Wolf MC, Aguilar HC, Enterlein S, Wang W, Muhlberger E, Su SV, Bertolotti-Ciarlet A, Flick R, Lee B (2006) Two key residues in Ephrinb3 are critical for its use as an alternative receptor for Nipah virus. PLoS Pathog 2(2):e7
68. O'Sullivan JD, Allworth AM, Paterson DL, Snow TM, Boots R, Gleeson LJ, Gould AR, Hyatt AD, Bradfield J (1997) Fatal encephalitis due to novel paramyxovirus transmitted from horses. Lancet 349(9045):93-95 (Pubitemid 27023426)
69. Pallister J, Middleton D, Crameri G, Yamada M, Klein R, Hancock TJ, Foord A, Shiell B, Michalski W, Broder CC, Wang LF (2009) Chloroquine administration does not prevent Nipah virus infection and disease in ferrets. J Virol 83(22):11979-11982
70. Pallister J, Middleton D, Broder CC, Wang LF (2011a) Henipavirus vaccine development. J Bioterr Biodef S1:005. doi:10.4172/2157-2526.S1-005
71. Pallister J, Middleton D, Wang LF, Klein R, Haining J, Robinson R, Yamada M, White J, Payne J, Feng YR, Chan YP, Broder CC (2011b) A recombinant hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal hendra virus challenge. Vaccine 29(34):5623-5630
72. Pantaleo G, Koup RA (2004) Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know. Nat Med 10(8):806-810 (Pubitemid 39070851)
73. Pasquale EB (2008) Eph-ephrin bidirectional signaling in physiology and disease. Cell 133(1):38-52 (Pubitemid 351442996)
74. Pasquale EB (2010) Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer 10(3):165-180
75. Playford EG, McCall B, Smith G, Slinko V, Allen G, Smith I, Moore F, Taylor C, Kung YH, Field H (2010) Human hendra virus encephalitis associated with equine outbreak, Australia 2008. Emerg Infect Dis 16(2):219-223
76. Rader C, Barbas CF 3rd (1997) Phage display of combinatorial antibody libraries. Curr Opin Biotechnol 8(4):503-508 (Pubitemid 27351290)
77. Rockx B, Bossart KN, Feldmann F, Geisbert JB, Hickey AC, Brining D, Callison J, Safronetz D, Marzi A, Kercher L, Long D, Broder CC, Feldmann H, Geisbert TW (2010) A novel model of lethal hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment. J Virol 84(19):9831-9839
78. Rockx B, Brining D, Kramer J, Callison J, Ebihara H, Mansfield K, Feldmann H (2011) Clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infection. J Virol 85(15):7658-7671
79. Rogers RJ, Douglas IC, Baldock FC, Glanville RJ, Seppanen KT, Gleeson LJ, Selleck PN, Dunn KJ (1996) Investigation of a second focus of equine morbillivirus infection in coastal Queensland. Aust Vet J 74(3):243-244
80. Selvey LA, Wells RM, McCormack JG, Ansford AJ, Murray K, Rogers RJ, Lavercombe PS, Selleck P, Sheridan JW (1995) Infection of humans and horses by a newly described morbillivirus. Med J Aust 162(12):642-645
81. Sendow I, Field HE, Curran J, Darminto, Morrissy C, Meehan G, Buick T, Daniels P (2006) Henipavirus in Pteropus vampyrus bats Indonesia. Emerg Infect Dis 12(4):711-712
82. Sendow I, Field HE, Curran J, Darminto, Morrissy C, Daniels P (2010) Screening for Nipah virus infection in west kalimantan province Indonesia. Zoonoses Public Health 57(7-8):499-503
83. Smith I, Broos A, de Jong C, Zeddeman A, Smith C, Smith G, Moore F, Barr J, Crameri G, Marsh G, Tachedjian M, Yu M, Kung YH, Wang LF, Field H (2011) Identifying hendra virus diversity in pteropid bats. PLoS One 6(9):e25275
84. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 101(16):6062-6067 (Pubitemid 38520528)
85. Tan CT, Wong KT (2003) Nipah encephalitis outbreak in Malaysia. Ann Acad Med Singapore 32(1):112-117 (Pubitemid 36433277)
86. Tan CT, Goh KJ, Wong KT, Sarji SA, Chua KB, Chew NK, Murugasu P, Loh YL, Chong HT, Tan KS, Thayaparan T, Kumar S, Jusoh MR (2002) Relapsed and late-onset Nipah encephalitis. Ann Neurol 51(6):703-708 (Pubitemid 34568848)
87. Wacharapluesadee S, Lumlertdacha B, Boongird K, Wanghongsa S, Chanhome L, Rollin P, Stockton P, Rupprecht CE, Ksiazek TG, Hemachudha T (2005) Bat Nipah virus Thailand. Emerg Infect Dis 11(12):1949-1951
88. Weingartl H, Czub S, Copps J, Berhane Y, Middleton D, Marszal P, Gren J, Smith G, Ganske S, Manning L, Czub M (2005) Invasion of the central nervous system in a porcine host by Nipah virus. J Virol 79(12):7528-7534 (Pubitemid 40756788)
89. Weingartl HM, Berhane Y, Caswell JL, Loosmore S, Audonnet JC, Roth JA, Czub M (2006) Recombinant Nipah virus vaccines protect pigs against challenge. J Virol 80(16):7929-7938 (Pubitemid 44182294)
90. Weingartl HM, Berhane Y, Czub M (2009) Animal models of henipavirus infection: a review. Vet J 181(3):211-220
91. Westbury HA, Hooper PT, Selleck PW, Murray PK (1995) Equine morbillivirus pneumonia: susceptibility of laboratory animals to the virus. Aust Vet J 72(7):278-279
92. Westbury HA, Hooper PT, Brouwer SL, Selleck PW (1996) Susceptibility of cats to equine morbillivirus. Aust Vet J 74(2):132-134 (Pubitemid 126475756)
93. White JR, Boyd V, Crameri GS, Duch CJ, van Laar RK, Wang LF, Eaton BT (2005) Location of, immunogenicity of and relationships between neutralization epitopes on the attachment protein (G) of hendra virus. J Gen Virol 86(Pt 10):2839-2848 (Pubitemid 41410476)
94. Wiley DC, Skehel JJ (1987) The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Ann. Rev. Biochem. 56:365-394
95. Williamson MM, Hooper PT, Selleck PW, Gleeson LJ, Daniels PW, Westbury HA, Murray PK (1998) Transmission studies of hendra virus (equine morbillivirus) in fruit bats, horses and cats. Aust Vet J 76(12):813-818
96. Wong KT (2010) Emerging epidemic viral encephalitides with a special focus on henipaviruses. Acta Neuropathol 120(3):317-325
97. Wong KT, Shieh WJ, Kumar S, Norain K, Abdullah W, Guarner J, Goldsmith CS, Chua KB, Lam SK, Tan CT, Goh KJ, Chong HT, Jusoh R, Rollin PE, Ksiazek TG, Zaki SR (2002) Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol 161(6):2153-2167 (Pubitemid 35434861)
98. Wong KT, Grosjean I, Brisson C, Blanquier B, Fevre-Montange M, Bernard A, Loth P, Georges-Courbot MC, Chevallier M, Akaoka H, Marianneau P, Lam SK, Wild TF, Deubel V (2003) A golden hamster model for human acute Nipah virus infection. Am J Pathol 163(5):2127-2137 (Pubitemid 37310041)
99. Wong KT, Robertson T, Ong BB, Chong JW, Yaiw KC, Wang LF, Ansford AJ, Tannenberg A (2009) Human hendra virus infection causes acute and relapsing encephalitis. Neuropathol Appl Neurobiol 35(3):296-305
100. Wright A, Shin SU, Morrison SL (1992) Genetically engineered antibodies: progress and prospects. Crit Rev Immunol 12(3-4):125-168 (Pubitemid 23014487)
101. Xu K, Rajashankar KR, Chan YP, Himanen JP, Broder CC, Nikolov DB (2008) Host cell recognition by the henipaviruses: crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3. Proc Natl Acad Sci U S A 105(29):9953-9958
102. Xu K, Khetawat D, Rajashankar KR, Chan YP, Kolev MV, Broder CC, Nikolov DB (2012) Crystal structures of the hendra virus G glycoprotein and its complex with ephrin-B2 reveal new insights into the virus attachment and entry process submitted (in press)
103. Yob JM, Field H, Rashdi AM, Morrissy C, van der Heide B, Rota P, bin Adzhar A, White J, Daniels P, Jamaluddin A, Ksiazek T (2001) Nipah virus infection in bats (order Chiroptera) in peninsular Malaysia. Emerg Infect Dis 7(3):439-441
104. Yuan P, Swanson KA, Leser GP, Paterson RG, Lamb RA, Jardetzky TS (2011) Structure of the newcastle disease virus hemagglutinin-neuraminidase (HN) ectodomain reveals a four-helix bundle stalk. Proc Natl Acad Sci U S A 108(36):14920-14925
105. Zhu Z, Dimitrov AS, Bossart KN, Crameri G, Bishop KA, Choudhry V, Mungall BA, Feng YR, Choudhary A, Zhang MY, Feng Y, Wang LF, Xiao X, Eaton BT, Broder CC, Dimitrov DS (2006) Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies. J Virol 80(2):891-899 (Pubitemid 43062901)
106. Zhu Z, Bossart KN, Bishop KA, Crameri G, Dimitrov AS, McEachern JA, Feng Y, Middleton D, Wang LF, Broder CC, Dimitrov DS (2008) Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody. J Infect Dis 197(6):846-853 (Pubitemid 351417007)